On the treatment of hemorrhage in patients with hemophilia and associated inhibitors

Transfusion. 2001 Dec;41(12):1628-9. doi: 10.1046/j.1537-2995.2001.41121628.x.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Coagulation Factors / therapeutic use
  • Decision Making
  • Factor VII / therapeutic use
  • Factor VIII / immunology
  • Factor VIII / therapeutic use
  • Factor VIIa
  • Hemophilia A / complications
  • Hemophilia A / drug therapy*
  • Hemophilia A / immunology
  • Hemorrhage / drug therapy*
  • Hemorrhage / etiology
  • Hemorrhage / prevention & control
  • Humans
  • Isoantibodies / blood
  • Recombinant Proteins / therapeutic use
  • Swine

Substances

  • Blood Coagulation Factors
  • Isoantibodies
  • Recombinant Proteins
  • prothrombin complex concentrates
  • Factor VII
  • Factor VIII
  • recombinant FVIIa
  • Factor VIIa